Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Adebayo A Adeniyi, Ramesh Muthusamy & Mahmoud ES Soliman. (2016) New drug design with covalent modifiers. Expert Opinion on Drug Discovery 11:1, pages 79-90.
Read now
Read now
WR Miller & J Jackson. (2003) The therapeutic potential of aromatase inhibitors. Expert Opinion on Investigational Drugs 12:3, pages 337-351.
Read now
Read now
Articles from other publishers (19)
Mariska de Munnik, Jasper Lithgow, Lennart Brewitz, Kirsten E. Christensen, Robert H. Bates, Beatriz Rodriguez-Miquel & Christopher J. Schofield. (2023) αβ,α′β′-Diepoxyketones are mechanism-based inhibitors of nucleophilic cysteine enzymes. Chemical Communications 59:86, pages 12859-12862.
Crossref
Crossref
Praful Pandey, Aparna Sharma & Ajay Gogia. (2023) Bone health in breast cancer. Current Problems in Cancer 47:3, pages 100959.
Crossref
Crossref
Matteo Malagrinò & Guido Zavatta. (2023) Review of bone health in women with estrogen receptor–positive breast cancer receiving endocrine therapy. Women's Health 19, pages 174550572211494.
Crossref
Crossref
Endri Karaj, Shaimaa H. Sindi, Nishanth Kuganesan, Lalith Perera, William Taylor & L. M. Viranga Tillekeratne. (2022) Tunable Cysteine-Targeting Electrophilic Heteroaromatic Warheads Induce Ferroptosis. Journal of Medicinal Chemistry 65:17, pages 11788-11817.
Crossref
Crossref
Neena Yadav, Arul Prakash Francis, Veeraraghavan Vishnu Priya, Shankargouda Patil, Shazia Mustaq, Sameer Saeed Khan, Khalid J. Alzahrani, Hamsa Jameel Banjer, Surapaneni Krishna Mohan, Ullas Mony & Rukkumani Rajagopalan. (2022) Polysaccharide-Drug Conjugates: A Tool for Enhanced Cancer Therapy. Polymers 14:5, pages 950.
Crossref
Crossref
Andrea R. Nikolić, Ivana Z. Kuzminac, Suzana S. Jovanović-Šanta, Dimitar S. Jakimov, Lidija D. Aleksić & Marija N. Sakač. (2018) Anticancer activity of novel steroidal 6-substituted 4-en-3-one D-seco dinitriles. Steroids 135, pages 101-107.
Crossref
Crossref
John Joseph Jayapal & Sangeetha Dhanaraj. (2017) Exemestane loaded alginate nanoparticles for cancer treatment: Formulation and in vitro evaluation. International Journal of Biological Macromolecules 105, pages 416-421.
Crossref
Crossref
Ana Filipa Sobral, Cristina Amaral, Georgina Correia-da-Silva & Natércia Teixeira. (2016) Unravelling exemestane: From biology to clinical prospects. The Journal of Steroid Biochemistry and Molecular Biology 163, pages 1-11.
Crossref
Crossref
Koushik Chandra, Priyadip Das, Samarasimhareddy Mamidi, Mattan Hurevich, Anat Iosub-Amir, Norman Metanis, Meital Reches & Assaf Friedler. (2016)
Covalent Inhibition of HIV-1 Integrase by
N
-Succinimidyl Peptides
. ChemMedChem 11:18, pages 1987-1994.
Crossref
Crossref
Carmen Avendaño & J. Carlos Menéndez. 2015. Medicinal Chemistry of Anticancer Drugs. Medicinal Chemistry of Anticancer Drugs
81
131
.
Ralf Buettner, Renzo Corzano, Rumana Rashid, Jianping Lin, Maheswari Senthil, Michael Hedvat, Anne Schroeder, Allen Mao, Andreas Herrmann, John Yim, Hongzhi Li, Yate-Ching Yuan, Kenichi Yakushijin, Fumiko Yakushijin, Nagarajan Vaidehi, Roger Moore, Gabriel Gugiu, Terry D. Lee, Richard Yip, Yuan Chen, Richard Jove, David Horne & John C. Williams. (2011) Alkylation of Cysteine 468 in Stat3 Defines a Novel Site for Therapeutic Development. ACS Chemical Biology 6:5, pages 432-443.
Crossref
Crossref
Juswinder Singh, Russell C. Petter, Thomas A. Baillie & Adrian Whitty. (2011) The resurgence of covalent drugs. Nature Reviews Drug Discovery 10:4, pages 307-317.
Crossref
Crossref
Shubham Pant & Charles L Shapiro. (2008) Aromatase Inhibitor-Associated Bone Loss. Drugs 68:18, pages 2591-2600.
Crossref
Crossref
Carmen Avendaño & J. Carlos Menéndez. 2008. Medicinal Chemistry of Anticancer Drugs. Medicinal Chemistry of Anticancer Drugs
53
91
.
A.R.K. Adesunkanmi, O.O. Lawal, K.A. Adelusola & M.A. Durosimi. (2006) The severity, outcome and challenges of breast cancer in Nigeria. The Breast 15:3, pages 399-409.
Crossref
Crossref
Constantine Gennatas, Vasiliki Michalaki, Eleni Carvounis, John Psychogios, Nikiforita Poulakaki, George Katsiamis, Dionysios Voros, Vasilis Kouloulias, Despina Mouratidou & Nikolaos Tsavaris. (2018) Third-Line Hormonal Treatment with Exemestane in Postmenopausal Patients with Advanced Breast Cancer Progressing on Letrozole or Anastrozole. A Phase II Trial Conducted by the Hellenic Group of Oncology (HELGO). Tumori Journal 92:1, pages 13-17.
Crossref
Crossref
Maria Almira Correia & Paul R. Ortiz de Montellano. 2005. Cytochrome P450. Cytochrome P450
247
322
.
W.R Miller. (2004) Biological rationale for endocrine therapy in breast cancer. Best Practice & Research Clinical Endocrinology & Metabolism 18:1, pages 1-32.
Crossref
Crossref
J Shields-Botella, P Bonnet, I Duc, E Duranti, S Meschi, S Cardinali, P Prouheze, A.M Chaigneau, V Duranti, S Gribaudo, A Rivière, L Mengual, D Carniato, L Cecchet, J Lafay, B Rondot, J Sandri, J.C Pascal & R Delansorne. (2003) In vitro and in vivo models for the evaluation of new inhibitors of human steroid sulfatase, devoid of residual estrogenic activity. The Journal of Steroid Biochemistry and Molecular Biology 84:2-3, pages 327-335.
Crossref
Crossref